Advertisement
Vitiligo can mask symptoms of acanthosis nigricans

Vitiligo Can Mask Symptoms of Acanthosis Nigricans

0
In this case report, masking could have resulted in delay of identification of ovarian cancer
There has been a 25 percent increase in the number of medical school enrollees since 2002

Increasing Numbers of Med School Applicants, Enrollees

0
Med school classes continuing to diversify, with increases in nearly every racial/ethnic category
Colorectal neoplasm is associated with smoking in a dose-response manner

Dose-Response Pattern for Smoking, Colorectal Neoplasm

0
Increase in non-advanced, advanced CRN with increasing smoking; no link for alcohol intake
A synchronized prescription renewal process can save physicians time and money

Synchronized Prescription Renewal Process Saves Time

0
Renewing all patient's stable medications for 12 to 15 months can save time and money
Cancer-associated incidental pulmonary embolism should be treated with low molecular weight heparins

Review Supports LMWH for Cancer-Linked Incidental PE

0
VTE recurrence risk similar under LMWHs, vitamin K antagonists; risk of major hemorrhage up under VKA
For patients with rheumatoid arthritis and inflammatory bowel disease with prior nonmelanoma skin cancer (NMSC)

Some RA Treatments Up Second Nonmelanoma Skin Cancer Risk

0
Increased risk with methotrexate, and for anti-TNF drugs in conjunction with methotrexate
Lynparza (olaparib) targets mutations found in about 30 percent of men with prostate cancer

Ovarian Cancer Rx Promising for Prostate Tumors

0
In small study, olaparib targeted gene mutation in men who had failed other therapy
The melanoma drug Yervoy (ipilimumab) can now be used to reduce the risk of the recurrence after surgery

FDA Approves Expanded Use for Melanoma Drug

0
Yervoy can now be used after surgery to reduce risk of skin cancer returning
Human papillomavirus vaccination rates among American girls remain too low

CDC: Not Enough Young Girls Getting HPV Vaccination

0
Need to increase delivery of the vaccine at the recommended ages of 11 or 12 years
Hidradenitis suppurativa can be associated with infectious and/or neoplastic fatal complications

Fatal Case of Hidradenitis Suppurativa Described

0
Case report describes fatal case of HS associated with sepsis and squamous cell carcinoma